from Babson College, Aleksey’s financial acumen is further illuminated in his transformative role as the CFO of CytoImmune Therapeutics where he secured over $100 million in funding. As the CFO of DIH International, Aleksey Krylov his strong commitment to fostering growth and innovation in the business world.